Journals / Turkish Journal of Hematology / 2007 / Cilt: 24 - Sayı: 1

Akut lenfoblastik lösemi hastasında intratekal metotreksata bağlı Cauda Equina sendromu

A case of Cauda Equina syndrome in a leukemic patient due to intrathecal methotrexate

Pages
28–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There are cases of CES developing after spinal anesthesia reported in the literature, but this is the first report of CES due to intrathecal methotrexate.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The leukemias may cause neurologic dysfunction through either direct invasion of the nervous system or indirectly through cytopenias, or it may occur as a result of the necessarily vigorous treatment programs for leukemia.
📊
Key Findings & Data:We report here a 24-year-old acute lymphoblastic leukemia patient who in her second cycle of hyper-CVAD chem therapy regimen (high-dose Ara-C and high-dose methotrexate) received intrathecal methotrexate and two days afterwards was diagnosed as having Cauda Equina syndrome (CES).
💡
Conclusion & Impact:There are cases of CES developing after spinal anesthesia reported in the literature, but this is the first report of CES due to intrathecal methotrexate.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Poliradikülopati · Uterus kanamaları · Methotreksat

Abstract

The leukemias may cause neurologic dysfunction through either direct invasion of the nervous system or indirectly through cytopenias, or it may occur as a result of the necessarily vigorous treatment programs for leukemia. We report here a 24-year-old acute lymphoblastic leukemia patient who in her second cycle of hyper-CVAD chem therapy regimen (high-dose Ara-C and high-dose methotrexate) received intrathecal methotrexate and two days afterwards was diagnosed as having Cauda Equina syndrome (CES). A lumbo-sacral MRI imaging with gadolinium was performed and there was a remarkable enhancement in the Cauda Equina region, suggesting either leukemic involvement or a type of neurologic complication associated with intrathecal methotrexate treatment. To rule out leukemic involvement, a lumbar puncture was performed and the CSF was free of leukemic cells. There are cases of CES developing after spinal anesthesia reported in the literature, but this is the first report of CES due to intrathecal methotrexate.

Özet

Lösemiler kendileri direk invazyon yoluyla ya da hematolojik parametrelerde oluşturdukları anomalilerle nörolojik bozukluklara yol açabildikleri gibi, lösemi tedavisinde yer alan santral sinir sistemi (SSS) profilaksi rejimleri de nörotoksisite oluşturabilmektedir. Intratekal kemoterapi, radyoterapi ve yüksek doz Ara-C ya da metotreksat içeren sistemik kemoterapiler SSS tutulumu proflaksisi veya tedavisinde etkindirler. İntratekal (IT) metotreksat tedavisi sonrası menenjial irritasyon bulgularına sık rastlanmakla beraber nadir olarak paralizi veya ensefalopati vakaları da bildirilmiştir. ALL-L1 tanısı konan 24 yaşında bir bayan hastaya Hyper-CVAD (yüksek doz Ara- C ve yüksek doz metotreksat) kemoterapi rejimi uygulanmaya başlandı. Hyper- CVAD kemoterapi rejiminin ikinci kürü sırasında, IT metotreksattan iki gün sonra hastamızda nörojenik mesane ve konstipasyon gelişti. Cauda Equina sendromu tanısı konan hastanın lumbo-sakral MRI görüntülemesinde Kauda Equina bölgesinde opaklaşma olduğu görüldü. Bu sırada yapılan lomber ponksiyon ve serebrospinal sıvı incelemesi ile bu opaklaşmanın lösemik tutuluma bağlı olmadığı kanıtlandı. Literatürde spinal anesteziye sekonder gelişen Cauda Equina sendromu bildirilmiş olsa da, vakamız intratekal metotreksat sonrası görülen ilk Cauda Equina sendromu vakasıdır.

🔖

Cite This Article

ATEŞOĞLU, E. B., TUĞCULAR, T. F., ADIGÜZEL, C., KAYGUSUZ, I., NOYAN, F., ÇETİNER, M., BAYIK, M. M. (2007). Akut lenfoblastik lösemi hastasında intratekal metotreksata bağlı Cauda Equina sendromu. Turkish Journal of Hematology, Cilt: 24 - Sayı: 1, 28–31. https://ajindex.com/articles/413222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Demopoulos A, DeAngelis LM. Neurologic complications of leukemia. Curr Opin Neurol 2002;15:691-9
  2. Watterson J, Toogood I, Nieder M, Morse M, Frierdich S, Lee Y, Moertel CL, Priest JR. Excessive spinal cord toxicity from intensive central nervous system directed therapies. Cancer 1994;74:3034-41
  3. Pochedly C. Neurotoxicity due to CNS therapy for leukemia. Med Pediatr Oncol 1977;3:101-15
  4. Orendacova J, Cizkova D, Kafka J, Nadezda L, Marsala M, Sulla I, Marsala J, Katsube N. Cauda Equina syndrome. Prog Neurobiol 2001;64:613-37
  5. Ozgen S, Baykan N, Dogan IV, Konya D, Pamir MN. Cauda Equina syndrome after induction of spinal anesthesia. Neurosurg Focus 2004;16:e5
  6. Ifuku Y, Iwagaki T, Irie J, Mekata K, Hirahara S, Uratsuji Y. Cauda Equina syndrome following intrathecal dibucaine. Masui 2004;53:396-8
  7. Pollock JE. Neurotoxicity of intrathecal local anesthetics and transient neurological symptoms. Best Pract Res Clin Anaesthesiol 2003;17:471-84 8. Ozon A, Topaloglu H, Cila A, Gunay M, Cetin M. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia. Brain Dev 1994;16:246-8
  8. Yim YS, Mahoney DH Jr, Oshman DG. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer 1991;67:2058-61
  9. Shore T, Barnett MJ, Philips GL. Sudden neurologic death after intrathecal methotrexate. Med Pediatr Oncol 1990;18:159-61
  10. Ochs JJ. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989;11:93-105
  11. Koh S, Nelson MD Jr, Kovanlikaya A, Chen LS. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment. Pediatr Neurol 1999;21:576-8